The third decade marks an important milestone for Pharex as a brand and company. In recent years, significant changes have occurred, with the company joining RiteMED and UNILAB for a bigger endeavor.
April 22, 2019
Pharex Launches Sorexidine Gargle
Pharex launches its first ever branded product, Sorexidine Gargle. Sorexidine is the gold standard microbicide for patients suffering from sore throat because of its proven efficacy against various categories of microbes including bacteria, fungi and viruses with high oral retentiveness up to 12 hours.
The launch started with the welcome remarks of Pharex president, Mr. Tomas Marcelo Agana III followed by an entertaining “Space Invaders” themed product reveal. One of the key highlights was the lecture of Dr. Melfred Hernandez, immediate past president of Philippine Society of Otolaryngology-Head & Neck Surgery on “Sorexidine: Soaring high over Sore Throat Troubles.” He explained the mechanism of action of Chlorhexidine gluconate and identified its unique properties and the superiority of Chlorhexidine gluconate as the “gold standard” compared to other brands. This was immediately followed by a lively panel discussion led by Dra. Teresa Luisa Cruz, a fellow of the Philippine Society of Otorhinolaryngology-Head and Neck Surgery and the Philippine College of Surgeons. There were many inquiries which showed high level of interest among the audience.
Sorexidine is the first ever branded product marketed by Pharex. Partner doctors from the ENT, Family Medicine, Internal Medicine and General Practitioners attended the event.
Sorexidine is available in 60ml at P94.00 and 120ml at P155.00.